Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.
about
Screening for nasopharyngeal cancerScreening for nasopharyngeal carcinomaEmerging treatment options for nasopharyngeal carcinomaTreatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapyUpdate on nasopharyngeal carcinomaClinical observation and quality of life in terms of nasal sinusitis after radiotherapy for nasopharyngeal carcinoma: long-term results from different nasal irrigation techniques.Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective StudyRole of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative RadiotherapyOmission of Chemotherapy in Early Stage Nasopharyngeal Carcinoma Treated with IMRT: A Paired Cohort Study.Frequency of Epstein Barr Virus Type 1 Among Nasopharyngeal Carcinomas in Iranian PatientsEfficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia.Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma.Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents.The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients.Alternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patientsControversies and challenges in the current management of nasopharyngeal cancer.Role of chemotherapy in stage IIb nasopharyngeal carcinomaCancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy.Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant.Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia.Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.Clinical verification of the superiority of the current International Union Against Cancer staging criteria in an Australian population of patients with nasopharyngeal carcinoma.Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.Chemotherapy use and survival in stage II nasopharyngeal carcinoma.Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option.Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort Study.Nasopharyngeal carcinoma: A review of current updates.Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
P2860
Q24187937-67972256-A6FD-4ED4-B441-50829476DB24Q24239852-8DCF6905-C8A2-4801-B477-D96C08DF856AQ26995560-39566904-834B-414A-ACCB-BAB4BDB7BDF0Q33579689-90F9590D-B33D-4503-8C72-BDD43F3DED07Q33594732-FA33E4D6-96DA-45C1-AEC0-130DA5A2E43CQ33823302-55A601A1-5C3A-48A9-851C-A2095918DEE1Q34662664-79A7B889-13A0-43DE-9AE6-FBE05341F567Q35974884-27B0B9D3-470B-4DEA-9EC2-F642A6B3CEA2Q36187049-B38C6D62-FB2E-4E61-BF6C-8351984D5094Q36195727-9F7AA35E-AB6B-4CD3-8935-8FA2F744335CQ36323473-02F7FEF8-90B4-4FB0-B8F4-899EC97D7748Q36324291-B70EB62A-716B-4231-81DA-2DB216382927Q36451599-1783FBA1-3FA3-4AA8-84D3-C760D6EB8BEEQ36774647-7734ECA5-74B7-467F-99C0-08FB7177F5CDQ36792351-775A45A3-890D-4101-B3D9-BBAA50DBC8DFQ37206380-924C61AC-60E3-4A5C-A6C8-5B563EF13C1BQ37370639-9195B123-F504-4C62-BAFD-3175C1A60A17Q37722215-007B2B9F-4F76-4554-9AE6-1492163E7450Q37788242-0EAB636D-F5A0-4AA1-9BAC-72E3A4565630Q38024880-FA6A07A3-FC5E-4153-9032-9CE930E5160AQ38243378-8F5311E4-7837-42F3-B605-E5E841C14C62Q38549748-33F7104C-234F-4040-835E-3215ED72C789Q40460639-C63EC002-6823-46FC-916A-B37ABBD00BCBQ40984597-5667C2E6-601C-4FC3-B91A-55339A4E5324Q44917316-3C91C64B-1FBE-4986-981C-A799F3B493E1Q45772336-D6803F0A-4901-4538-971A-81C37EB8C7D0Q47095931-FC4942BB-B93C-4CDA-8395-064801950251Q47767561-8B5F6871-000E-4A16-BFAF-E70B6659E37CQ50431396-A776BAFE-51AF-40A8-8EB6-2CE6A5931E3DQ52576030-725C97B3-7DD6-4F7E-A36D-FEACF153E253Q54252954-AD9D7DE8-A26A-4DB5-BE4C-03AFE4AC506EQ58596042-A6B9EE54-7C12-43A3-B894-7D9DE1FC7876
P2860
Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@ast
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@en
type
label
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@ast
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@en
prefLabel
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@ast
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@en
P2093
P356
P1433
P1476
Treatment outcome after radiot ...... I-II nasopharyngeal carcinoma.
@en
P2093
Daniel T T Chua
Dora L W Kwong
Gordon K H Au
Jonathan S T Sham
P356
10.1002/CNCR.11485
P407
P577
2003-07-01T00:00:00Z